SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Arterial Vascular Engineering AVEI

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tim Bagwell who wrote (264)7/6/1998 2:59:00 PM
From: Jeffrey L. Henken  Read Replies (1) of 410
 
I called Diane Lefebvre at AVE. This is what she told me. Earnings will be out after the close July 20th.

Any rumor about a JNJ acquisition is just a rumor.

Diane and I discussed just how great a deal the acquisition of Cordis was for Cordis(NOT!). AVE wants to go it alone and why wouldn't they!

AVEI is certainly looking to broaden their product line through acquisitions of their own. They certainly will not be making 10 to 12 actual acquisitions but there will be more deals besides just the one that was done with World Medical.

She was very pleased to point out that AVE has signed all their recent deals like the one with Tenet despite the fact that they do not bundle their stent products. The company is making a great product in strong demand.

biz.yahoo.com

It's my belief that AVE is definitely in the drivers seat in the stent market.

Even the TA followers are likely to find AVEI a stong buy soon.

Regards, Jeff
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext